Back to Overview
Martin Fabry PhD
Martin Fabry finished his bachelor’s degree in molecular biomedicine at the University of Bonn in 2014 and moved to the US as a visiting scientist at Cold Spring Harbor Laboratory (New York, US) working on improving CRISPR/Cas9 technologies. Following completion of a master’s degree in life and medical sciences in 2016 with emphasis on molecular mechanisms of immunity, Martin started his PhD in Medical Sciences with Cancer Research UK at the University of Cambridge studying genome organisation and stability.
After graduating with his doctorate degree in 2020, Martin worked as postdoctoral fellow in computational biology at the Gurdon Institute and European Bioinformatics Institute (EBI) in Cambridge with focus on stem cell development and establishing new technologies for stem cell differentiation.
Martin joined IP2 in 2018 as scientific consultant and started as a patent attorney candidate in late 2021.
- Life Science 100%
What more there is to say...
In his leisure time Martin likes running, hiking, diving and rowing.
What moves me
EPO’s start-up offensive – not a big hit
It is a truism that newly founded, highly innovative companies are particularly dependent on the protection of their intellectual property, but often lack the budget to ensure this in a comprehensive manner. This is doubly fatal, as IP is usually the only asset that...
Euro Bank notes – turn around and see
Always trouble around the Euro We all have colorful euro bills in our hands every day, but hand on heart: do you know what is depicted on these banknotes? I also had to look it up: on the front there are examples of architecture from different centuries and next to it...
Pitfalls for Patent Filing
Part I: When insufficient disclosure becomes a case (1) In this new section of our blog, we want to deal with the pitfalls that cause patent applications to fail again and again without need. The main focus will be on current decisions of the EPO and the German...
Back to Overview